1. Home
  2. BJDX vs SNES Comparison

BJDX vs SNES Comparison

Compare BJDX & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BJDX
  • SNES
  • Stock Information
  • Founded
  • BJDX 2015
  • SNES 2004
  • Country
  • BJDX United States
  • SNES United States
  • Employees
  • BJDX N/A
  • SNES N/A
  • Industry
  • BJDX Medical Specialities
  • SNES Agricultural Chemicals
  • Sector
  • BJDX Health Care
  • SNES Industrials
  • Exchange
  • BJDX Nasdaq
  • SNES Nasdaq
  • Market Cap
  • BJDX 2.1M
  • SNES 2.3M
  • IPO Year
  • BJDX 2021
  • SNES 2016
  • Fundamental
  • Price
  • BJDX $3.45
  • SNES $3.03
  • Analyst Decision
  • BJDX
  • SNES Strong Buy
  • Analyst Count
  • BJDX 0
  • SNES 1
  • Target Price
  • BJDX N/A
  • SNES $10.00
  • AVG Volume (30 Days)
  • BJDX 43.6K
  • SNES 97.2K
  • Earning Date
  • BJDX 03-27-2025
  • SNES 02-28-2025
  • Dividend Yield
  • BJDX N/A
  • SNES N/A
  • EPS Growth
  • BJDX N/A
  • SNES N/A
  • EPS
  • BJDX N/A
  • SNES N/A
  • Revenue
  • BJDX N/A
  • SNES $1,651,000.00
  • Revenue This Year
  • BJDX N/A
  • SNES $76.36
  • Revenue Next Year
  • BJDX N/A
  • SNES $103.47
  • P/E Ratio
  • BJDX N/A
  • SNES N/A
  • Revenue Growth
  • BJDX N/A
  • SNES 38.16
  • 52 Week Low
  • BJDX $3.03
  • SNES $1.90
  • 52 Week High
  • BJDX $386.80
  • SNES $9.80
  • Technical
  • Relative Strength Index (RSI)
  • BJDX 45.28
  • SNES 47.13
  • Support Level
  • BJDX $3.37
  • SNES $3.18
  • Resistance Level
  • BJDX $3.83
  • SNES $3.63
  • Average True Range (ATR)
  • BJDX 0.24
  • SNES 0.42
  • MACD
  • BJDX -0.00
  • SNES 0.00
  • Stochastic Oscillator
  • BJDX 24.00
  • SNES 31.26

About BJDX Bluejay Diagnostics Inc.

Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.

About SNES SenesTech Inc.

SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.

Share on Social Networks: